Herlev Hospital, Herlev Ringvej 75
Building: 81-05-PV9
2730 Herlev
Denmark
Multiple myeloma; Immunotherapy
Peptide vaccination; Multiple myeloma
Phase one first in human trial on peptide vaccination against PD-L1 in multiple myeloma.
Laboratoy investigations of PD-L1 immune responses in leukapheresis products from patients with multiple myeloma.
None
ID: 45967723